🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great read from Akila Quinio on a worrying legacy of France's elections: "The campaign emboldened extremists at a time when tensions in French society were already running high. Minorities were the first to pay the price" on.ft.com/3S2ahwD via @financialtimes

Von der Leyen commission unlawfully concealed Covid vaccine contracts details, court finds, in legal blow to her crunch re-election bid in parliament tomorrow ft.com/content/36cc0a… @ft w Andrew Bounds daria mosolova & alicemhancock

The NHS has prescribed weight loss drug Wegovy far less than expected since its UK launch, leaving patients on waiting lists while wealthier users pay out of pocket 💉 New in ⁦Financial Times⁩ with ⁦Clara Murray⁩ on.ft.com/46pUEoI

More FT pharma new: US recommendations for the world's first RSV vaccines will shrink their sales, in a blow to jab makers GSK, Pfizer and Moderna ft.com/content/8c21c6… via @ft

AstraZeneca calls on Labour to change rules on innovative drug pricing Stretched healthcare systems are assessing whether they can afford the high cost of innovative new treatments that have boosted pharmaceutical companies’ sales. ft.com/content/466a4d… via @ft

NEW: Inside the race to make the world’s fastest running shoes. We worked with Lumafield to CT-scan the latest Nike and Adidas models and reveal the technology propelling record-breaking long-distance runners. W/ Sara Germano Dan Clark Irene de la Torre Arenas ft.com/running-shoes

A rising number of women are seeking private IVF treatments in England as the NHS rolls back funding for fertility services. With birth rates falling, academics and charities are calling for a national policy for providing treatment across the NHS. on.ft.com/46teKy4

EU warned new medical trial rules will slow approval of vital treatments via Financial Times with ⁦Ian Johnston⁩ on.ft.com/3AlGDfT

How Big Tech is quietly trying to reshape how pollution is reported on.ft.com/3YIEzs7

AstraZeneca vaccine project in doubt as UK Treasury seeks to cut state aid ft.com/content/633f1f… via @ft

A little known tale: Swiss pharma group Roche, which is pitching itself to investors as a new weight loss contender, passed on an anti-obesity pill that would become Eli Lilly's potential mega-blockbuster orforglipron for less than $50mn upfront. Story with Ian Johnston

Haunting quote: “Pancreatic cancer does not have patient advocates because they all die,” said Julie Fleshman, chief executive of the Pancreatic Cancer Action Network. Mine and Ian Johnston's long read on R&D struggles with the hardest-to-treat cancers ft.com/content/cc3e83…

Roche data shows stomach-churning side effects of weight-loss drugs on.ft.com/4gq8lsc

Ladies and gentlemen, Financial Times data genius John Burn-Murdoch has called it: weight loss drugs are causing a fall in obesity rates in the US. This is monumental.

23andMe was the toast of Silicon Valley in 2021. Now lawyers suing it over a data breach of 7mn users want a cut-price compensation deal before it runs out of cash Story on the genetics testing company with Stephanie Stacey and George Hammond: on.ft.com/3YaDDuO

"Customers pay to spit into a tube, mail it back and learn what is written in their genes... the problem is that after the big reveal, there is not much scope for recurring business" Sharp follow-up to our piece on 23andMe's problems from FT's Lex: on.ft.com/4f58srQ

Do Gen Z have it harder than any other generation? I dug into the data on housing, jobs and mental health for Financial Times to see if the outlook for today's young adults is really more bleak than ever before... on.ft.com/3UBZD0B

NEW: Are the robots finally coming? In our latest visual story, Lucy Rodgers Sam Learner Irene de la Torre Arenas Ian Bott Michael Peel Peter Andringa Justine Williams Caroline Nevitt Dan Clark explain how AI is powering a robotics revolution. 🤖👉 ft.com/ai-robots

Great profile of François Bayrou by Leila Abboud Ben Hall Ian Johnston ‘The original centrist’: France’s new prime minister seizes his moment ft.com/content/7d2786… via @ft

I thought I was reading a similar thing about the EU not so long ago... ENGIE CEO tells Ian Johnston that the company could switch investment away from the US because of uncertainty on tariffs and credits ft.com/content/f89d58…